跳转至内容
Merck
CN
  • Electrospun collagen/poly(L-lactic acid-co-epsilon-caprolactone) hybrid nanofibrous membranes combining with sandwich construction model for cartilage tissue engineering.

Electrospun collagen/poly(L-lactic acid-co-epsilon-caprolactone) hybrid nanofibrous membranes combining with sandwich construction model for cartilage tissue engineering.

Journal of nanoscience and nanotechnology (2013-07-19)
Xiaomin He, Wei Fu, Bei Feng, Hao Wang, Zhenling Liu, Meng Yin, Wei Wang, Jinghao Zheng
摘要

Electrospinning has recently received much attention, showing great potential as a novel scaffold fabrication method for cartilage tissue engineering. In this study, we developed a biodegradable hybrid nanofibrous membrane of collagen and poly(L-lactic acid-co-epsilon-caprolactone) (PLCL, 75:25) by electrospinning for cartilage tissue engineering. The structure and cell affinity of collagen/PLCL membranes were analyzed by scanning electron microscopy (SEM) and microscopy. The sandwiched cell-scaffold constructs were kept in culture for 1 week in vitro and then implanted subcutaneously into nude mice for 4, 8 and 12 weeks. Gross observation, histological and immunohistological evaluation, glycosaminoglycan (GAG) analysis and Young's modulus measurements were performed at each post-implantation time-point. Electrospun collagen/PLCL nanofibrous membranes could mimic the natural ECM and have good cell affinity. All the cell-scaffold constructs showed cartilage-like morphology with a white, smooth and glistening appearance after 4, 8 and 12 weeks of implantation. The abundance of GAG containing cartilaginous matrix appeared to increase greatly with implantation time. Furthermore, well-distributed cartilage and nearly no empty areas were observed in constructs even at 12 weeks post-implantation. In addition, the mechanical properties of the engineered cartilage after 12 weeks of implantation could reach 83% of that of native rabbit auricular cartilage. These results indicate that collagen/PLCL nanofibrous membranes with the sandwich construction model may serve as a new approach for cartilage tissue engineering.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
胶原蛋白 来源于人类胎盘, Bornstein and Traub Type IV, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
I型胶原蛋白 溶液 来源于大鼠尾, BioReagent, suitable for cell culture, sterile-filtered
Sigma-Aldrich
胶原蛋白 来源于人类胎盘, Bornstein and Traub Type IV, powder
Sigma-Aldrich
乳酸, meets USP testing specifications
Sigma-Aldrich
胶原蛋白 来源于大鼠尾, Bornstein and Traub Type I, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
乳酸, 88%, FCC
Sigma-Aldrich
聚乳酸, Mw ~60,000
Sigma-Aldrich
乳酸, natural, ≥85%
Sigma-Aldrich
胶原蛋白 来源于鸡胸软骨, Type II (Miller), powder, BioReagent, suitable for cell culture
Sigma-Aldrich
胶原蛋白 来源于小牛皮, Bornstein and Traub Type I, (0.1% solution in 0.1 M acetic acid), aseptically processed, BioReagent, suitable for cell culture
Sigma-Aldrich
乳酸 溶液, ACS reagent, ≥85%
Sigma-Aldrich
胶原蛋白IV型 来源于人类细胞培养基, Bornstein and Traub Type IV, 0.3 mg/mL, sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
胶原蛋白 来源于人类胎盘, Bornstein and Traub Type I (Sigma Type VIII), powder
Sigma-Aldrich
DL-乳酸, ~90% (T)
Supelco
乳酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
DL-乳酸, 85 % (w/w), syrup
Sigma-Aldrich
胶原 人, Bornstein and Traub Type I, acid soluble, powder, ~95% (SDS-PAGE)
Sigma-Aldrich
胶原蛋白 来源于人类胎盘, Bornstein and Traub Type III (Sigma Type X), powder
Sigma-Aldrich
胶原蛋白 来源于 Engelbreth-Holm-Swarm 小鼠肉瘤基底膜, Type IV (Miller), lyophilized powder, BioReagent, suitable for cell culture
Sigma-Aldrich
胶原蛋白 来源于人类胎盘, Bornstein and Traub Type IV, solution, suitable for cell culture, High Performance
Sigma-Aldrich
胶原蛋白 来源于人类胎盘, Bornstein and Traub Type V (Sigma Type IX), powder
Sigma-Aldrich
胶原 来源于人类胎盘, Bornstein and Traub Type IV, powder